Milwaukee shoulder syndrome: a neglected and underrecognized basic calcium phosphate crystal arthropathy

Milwaukee Shoulder Syndrome (MSS) is a rare but extremely aggressive form of destructive arthropathy, primarily affecting elderly women. Despite its distinct clinical profile, it remains an under-recognized and frequently misdiagnosed entity. This review synthesizes current knowledge on pathogenesis, clinical presentation, and diagnostic nuances of MSS to improve clinical recognition. The condition is defined by the intra-articular deposition of basic calcium phosphate (BCP) crystals, such as hydroxyapatite. These crystals trigger the release of proteolytic enzymes, leading to massive rotator cuff tears, superior migration of the humeral head, and rapid joint destruction. A hallmark of MSS is the "inflammatory paradox": a striking dissociation between severe structural damage and a non-inflammatory or minimally inflammatory synovial fluid profile (typically < 2,000 cells/mm3), which often is hemorrhagic. Diagnosis is challenged by the nanocrystalline nature of BCP crystals, which are non-birefringent and invisible under standard polarized light microscopy, requiring specialized staining (Alizarin Red) or advanced analytics for confirmation. Multimodal imaging is essential, with plain radiography showing advanced degeneration and MRI or CT delineating the extent of soft tissue and bony destruction. Treatment is currently limited to supportive measures, including recurrent joint aspiration, analgesia, and physical therapy. In advanced cases, reverse total shoulder arthroplasty remains the primary surgical intervention for functional restoration. As the aging population grows, increasing clinician awareness of MSS-particularly its unique synovial fluid characteristics-is vital for reducing diagnostic delay and optimizing patient care.